The side effects associated with Equipoise are generally mild. The structure of boldenone does allow it to convert into estrogen, but it does not have an extremely high affinity to do so. To try and quantify this we can look toward aromatization studies, which suggest that its rate of estrogen conversion should be roughly half that of testosterone’s. The tendency to develop a noticeable amount of water retention with this drug would therefore be slightly higher than that with Deca-Durabolin (with an estimated 20°/a conversion), but much less than what would be expected with a stronger agent such as Testosterone. While one does still have a chance of encountering an estrogen related side effect as such when using this substance, it is not a common problem when taken at a moderate dosage level. Gynecomastia might theoretically become a concern, but is usually only heaved of with very sensitive individuals or (again) those venturing high in dosage. Should estrogenic effects become troublesome, the addition of proper acilliary would be highly recommended making the cycle more tolerable. An antiaromatase such as Cytadren® or Arimidex would be stronger options, however probably not indicated with a mild drug as such.
Register for alerts
If you have registered for alerts, you should use your registered email address as your username
In the past, the principal reason for Equipoises use was its easy availability as a Mexican veterinary product. Presently, for the most part there is little specific reason to use Equipoise in an anabolic steroid cycle. There is nothing that it does anabolically that Masteron, Primobolan, Deca, or trenbolone will not do. In terms of side effects, likewise it has no advantage over Masteron or Primobolan, unless one desires the occasional side effect of increased appetite, or the side effect of its moderate conversion to estrogen. This can be useful if no other aromatizing steroid is being used.